Neurosyphilis

Jump to navigation Jump to search

For patient information on Neurosyphilis, click here

Template:DiseaseDisorder infobox

Sexually transmitted diseases Main Page

Syphilis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Syphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary and Secondary Syphilis
Latent Syphilis
Tertiary Syphilis
Neurosyphilis
HIV-Infected Patients
Pregnancy
Management of Sexual Partners

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurosyphilis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurosyphilis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurosyphilis

CDC on Neurosyphilis

Neurosyphilis in the news

Blogs on Neurosyphilis

Directions to Hospitals Treating Syphilis

Risk calculators and risk factors for Neurosyphilis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

  • Neurosyphilis may occur at any stage of syphilis.
  • Before the advent of antibiotics, it was typically seen in 25-35% of patients with syphilis.
  • Neurosyphilis is now most common in patients with HIV infection. Reports of neurosyphilis in HIV-infected persons are similar to cases reported before the HIV pandemic. The precise extent and significance of neurologic involvement in HIV-infected patients with syphilis, reflected by either laboratory or clinical criteria, have not been well characterized. Furthermore, the alteration of host immunosuppression by antiretroviral therapy in recent years has further complicated such characterization.

Clinical presentation

  • An abnormal leukocyte cell count, protein level, or glucose level
  • Demonstrated reactivity to Venereal Disease Research Laboratory (VDRL) antibody test

Four clinical types

  • The late forms of neurosyphilis (tabes dorsalis and general paresis) are seen much less frequently since the advent of antibiotics.
  • The most common manifestations today are asymptomatic or symptomatic meningitis.
1. Asymptomatic symptomatic meningitis
  • Acute syphilitic meningitis usually occurs within the first year of infection; 10% of cases are diagnosed at the time of the secondary rash.
  • Rarely, it affects the spine instead of the brain, causing focal muscle weakness or sensory loss.
2. Meningovascular syphilis
  • Meningovascular syphilis occurs a few months to 10 years (average, 7 years) after the primary syphilis infection.
  • Meningovascular syphilis can be associated with prodromal symptoms lasting weeks to months before focal deficits are identifiable.
  • Prodromal symptoms include:
  • The focal deficits initially are intermittent or progress slowly over a few days.
  • However, it can also present as an infectious arteritis and cause an ischemic stroke, an outcome more commonly seen in younger patients.
  • Angiography may be able to demonstrate areas of narrowing in the blood vessels or total occlusion.

Related chapters

Resources

Template:STD/STI

Template:Spirochetal diseases


Template:WikiDoc Sources